A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.

• मुख्य लेखकों: Nicholas O Opoku (लेखक), Felix Doe (लेखक), Bettina Dubben (लेखक), Nicole Fetcho (लेखक), Kerstin Fischer (लेखक), Peter U Fischer (लेखक), Shelter Gordor (लेखक), Charles W Goss (लेखक), Michael E Gyasi (लेखक), Achim Hoerauf (लेखक), Augustine R Hong (लेखक), Eric Kanza (लेखक), Christopher L King (लेखक), Ruth Laryea (लेखक), Daphne Lew (लेखक), Mahmood A Seidu (लेखक), Gary J Weil (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Public Library of Science (PLoS), 2023-05-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

<h4>Background</h4>Onchocerciasis ("river blindness") has been targeted for elimination. New treatments that kill or permanently sterilize female worms could accelerate this process. Prior studies have shown that triple drug treatment with ivermectin plus diethylcarbamazine and...